March for Science
Mary Woolley, president and CEO, Research!America was profiled on the Bio Report podcast to discuss the second annual March for Science, public perception of science, and the state of funding for science in the United States.
Woolley was quoted in The Washington Post and Buzzfeed about the importance of events like the March for Science in connecting with non-scientists.. “This is all about making science visible to the public.”
Research!America board member Rush D. Holt, Ph.D., CEO, American Association for the Advancement of Science, was profiled in The Scientist about researchers’ involvement in the event. “The March for Science has become an important symbol, as well as an important occurrence, because it reminds scientists and the public that there is a public dimension to the work of scientists, and an obligation of scientists to create and maintain the support of the society in which they work.”
In a Morning Consult article about the proposed Senate and House bills to combat the opioid crisis Georges Benjamin, M.D., executive director, American Public Health Association, commented that a continuous, reliable funding stream is essential to tackling the opioid epidemic.
Research!America board member Harold L. Paz, M.D., M.S., EVP and CMO, Aetna, was quoted in a Health IT Analytics article about Aetna and Harvard T.H. Chan School for Public Health’s new population health research initiative. “Our work with faculty at the Harvard Chan School will provide us with a wealth of data on this subject, allowing us to enhance our strategy and create innovative new programs that can help improve the well-being of those we serve.”
Election Year and Science
The Journal & Courier (Indiana) published a letter-to-the-editor penned by Woolley urging scientists to engage with the public and decision-makers to elevate the visibility of the research enterprise. “Encourage others to join the movement to make science a higher national priority – including candidates running for office this election year.”
Research!America board member Elias Zerhouni, M.D., president, global research and development, Sanofi, was quoted in a Bloomberg article about duplication of efforts in the drug development process.
Cost of Caregiving
In a Medscape article about a new analysis from the American Heart Association analyzing the cost of informal caregiving for patients with heart disease and stroke, Research!America board member Nancy Brown, CEO, American Heart Association, commented on the increased burden placed on family members and friends caring for patients outside the formal health care system.
In an Fierce Healthcare article about the American Medical Association’s (AMA) investment into Health2047, an innovation enterprise, Research!America board member James Madara, M.D., EVP and CEO, AMA said that the support helps “improve both care delivery and health outcomes to benefit the nation’s physicians and their patients.”